N,N dimethyltryptamine - Mindmed
Alternative Names: Dimethyltryptamine - Mindmed; DMT - Mindmed; N,N-Dimethyltryptamine - MindmedLatest Information Update: 28 Aug 2024
At a glance
- Originator The University Hospital of Basel
- Developer Mindmed; The University Hospital of Basel
- Class Antidepressants; Antipsychotics; Dimethylamines; Drug withdrawal therapies; Neuropsychotherapeutics; Small molecules; Tryptamines; Vascular disorder therapies
- Mechanism of Action Neuron modulators; Serotonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Mental disorders; Substance-related disorders
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for phase-I development in Mental-disorders(In volunteers) in Switzerland (IV)
- 28 Jul 2024 No recent reports of development identified for preclinical development in Mental-disorders in USA (IV)
- 28 Jul 2024 No recent reports of development identified for preclinical development in Substance-related disorders in Switzerland (IV)